Iteos Therapeutics Inc share price logo

Iteos Therapeutics Inc Share Price

NASDAQ: ITOS

$10.17

+0.04

(+0.39%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 28 Aug 2025

Iteos Therapeutics Inc Stock Performance

as on August 29, 2025 at 1:29 am IST

  • Day's Low

    $10.14
    $10.17
    downward going graph

    0.29%

    Downside

  • 52 Week's Low

    52 Week's High

    $4.8
    $17.63
    downward going graph

    52.80%

    Downside

    73.35%

    Upside

    downward going graph

Iteos Therapeutics Inc share price movements today

Previous Close
$10.13
Open
$10.14
Volume
5.1M
Day's Low - High
$10.14 - $10.17
52 Week Low - High
$4.8 - $17.63

Iteos Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Iteos Therapeutics Inc Stock Fundamentals & Key Indicators

Check Iteos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Iteos Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iteos Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%
BUY$63.2B297.83%-505.15-12.96%
NA$39.8BNANA-3.89%
BUY$101.7B55.09%28.1631.86%
BUY$59.0B1.52%14.0331.37%

Analyst Recommendation on Iteos Therapeutics Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Iteos Therapeutics Inc. Average target price of $10.3

Iteos Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Iteos Therapeutics Inc.

What analysts predicted

1.26%UPSIDE

Target Price

$10.3

Current Price

$10.17

Analyzed by

11 Analysts

Target

$10.30

Iteos Therapeutics Inc target price $10.3, a slight upside of 1.26% compared to current price of $10.17. According to 11 analysts rating.

Iteos Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
12
-
-
-11
-
35
-
-
-
-
Gross Profit
12
0
0
-11
0
34
0
-34
0
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-15
-34
-32
-30
-38
-7
-45
-43
-34
-78
Net Profit Margin
-123.47%
0.00%
0.00%
270.29%
0.00%
-20.37%
0.00%
0.00%
0.00%
0.00%

Iteos Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
344
267
12
35
Gross Profit
0
0
0
344
266
11
33
Operating Income
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-18
-22
-38
214
96
-112
-134
Net Profit Margin
0.00%
0.00%
0.00%
62.22%
36.11%
-894.34%
-384.04%

Global Institutional Holdings in Iteos Therapeutics Inc

Funds
Holdings
BlackRock Inc
10.21%
RA Capital Management, LLC
8.26%
Bvf Inc
6.96%
Mpm Asset Management, LLC
6.2%
TANG CAPITAL MANAGEMENT LLC
6.09%

Insights on Iteos Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ITOS stock has moved up by 40.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -11.30M → 35.0M (in $), with an average increase of 132.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 171.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 97.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -34.61M → -78.72M (in $), with an average decrease of 127.5% per quarter

About Iteos Therapeutics Inc

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its EOS-984, a potentially first-in-class small molecule, focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1, a dominant transporter of extracellular adenosine, expressed on intratumoral T cells, which allows adenosine entry into the cell, disturbing T cell metabolism, expansion, effector function, and survival. It is also developing EOS-215, a potential best-in-class monoclonal antibody which antagonizes the triggering receptor expressed on myeloid cells 2.
OrganisationIteos Therapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Iteos Therapeutics Inc share price today?

Iteos Therapeutics Inc share price today is $10.17 as on at the close of the market. Iteos Therapeutics Inc share today touched a day high of $10.17 and a low of $10.14.

What is the 52 week high and 52 week low for Iteos Therapeutics Inc share?

Iteos Therapeutics Inc share touched a 52 week high of $17.63 on and a 52 week low of $4.8 on . Iteos Therapeutics Inc stock price today i.e. is closed at $10.17,which is 42.31% down from its 52 week high and 111.88% up from its 52 week low.

How to invest in Iteos Therapeutics Inc Stock (ITOS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Iteos Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iteos Therapeutics Inc Shares that will get you 0.1475 shares as per Iteos Therapeutics Inc share price of $10.17 per share as on August 29, 2025 at 1:29 am IST.

What is the minimum amount required to buy Iteos Therapeutics Inc Stock (ITOS) from India?

Indian investors can start investing in Iteos Therapeutics Inc (ITOS) shares with as little as ₹88.098 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.98 in Iteos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Iteos Therapeutics Inc share’s latest price of $10.17 as on August 29, 2025 at 1:29 am IST, you will get 0.9833 shares of Iteos Therapeutics Inc. Learn more about fractional shares .